Johnson & Johnson (JNJ) has risen sharply, recording gains of 1.13% in the past 4 weeks. However, the stock has corrected -0.79% in the past 1 week, providing a good buying opportunity on dips. Johnson & Johnson (JNJ) : During the past 4 weeks, traders have been relatively bearish on Johnson & Johnson (JNJ), hence the stock is down -1.32% when compared to the S&P 500 during the same period. However, in the past 1 week, the selling of the stock is down by -1.21% relative to the S&P 500.
Johnson & Johnson (NYSE:JNJ): During Fridays trading session, Bulls were in full control of the stock right from the opening. The stock opened at $124.38 and $123.76 proved to be the low of the day. Continuous buying at higher levels pushed the stock towards an intraday high of $124.38. The buying momentum continued till the end and the stock did not give up its gains. It closed at $124.24, notching a gain of 0.31% for the day. The total traded volume was 5,146,935 . The stock had closed at $123.86 on the previous day.
The stock has recorded a 20-day Moving Average of 0.03% and the 50-Day Moving Average is 3.74%. Johnson & Johnson is up 10.99% in the last 3-month period. Year-to-Date the stock performance stands at 22.7%.
Johnson & Johnson (JNJ) : The highest level Johnson & Johnson (JNJ) is projected to reach is $142 for the short term and the lowest estimate is at $93. The consolidated price target from 13 rating analysts who initiate coverage on the stock is $125 and the possibility the share price can swing is $14.48.
Johnson & Johnson is a holding company. The Company is engaged in the research and development, manufacture and sale of a range of products in the health care field. The Company has more than 265 operating companies conducting business around the world. The Companys primary focus is products related to human health and well-being. The Company is organized into three business segments: Consumer, Pharmaceutical and Medical Devices. The Companys subsidiaries operate 134 manufacturing facilities occupying approximately 21.5 million square feet of floor space. The Companys research facilities are located in the United States, Belgium, Brazil, Canada, China, France, Germany, India, Israel, Japan, the Netherlands, Singapore, Switzerland and the United Kingdom.